Beta Bionics, Inc. (BBNX)
(Delayed Data from NSDQ)
$21.13 USD
-1.21 (-5.42%)
Updated Oct 15, 2025 04:00 PM ET
After-Market: $21.12 -0.01 (-0.05%) 6:56 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BBNX 21.13 -1.21(-5.42%)
Will BBNX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for BBNX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BBNX
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
BBNX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BBNX
20 Day Moving Average Support appears for BBNX after 0.86% move
Crossed Above 20 Day Moving Average appears for BBNX after 5.33% move
Is BBNX signaling selling opportunity? 20 Day Moving Average Resistance shows up after crashing 5.4%
Is BBNX positioned for a breakdown? 20 Day Moving Average Resistance shows up after gaining 0.45%
BBNX forms 20 Day Moving Average Resistance on October 8